GlassScriptPhysician profile
Nathan D Pfeifer
NPI 1750948188
$1,311.30
in general payments reported to CMS, 2019-2025
16 companies · $553 in 2025
The $553 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $53.81 · 2023: $208 · 2024: $497 · 2025: $553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,257.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $347.07 | 2023-2025 | Breztri, Airsupra, Farxiga |
| Medtronic, INC. | $151.43 | 2025 | Intellis Adaptivestim, Symplicity G3 |
| Novo Nordisk INC | $122.86 | 2023-2024 | Ozempic, Rybelsus |
| Pfizer INC. | $106.88 | 2023-2025 | |
| Grifols USA, LLC | $96.08 | 2024-2025 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $93.86 | 2022-2024 | Jardiance, Ofev |
| Lilly USA, LLC | $89.46 | 2023-2025 | Mounjaro, Jardiance, Emgality |
| Novartis Pharmaceuticals Corporation | $65.30 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $57.52 | 2024-2025 | Gemtesa |
| Amgen INC. | $45.34 | 2023-2025 | Evenity, Prolia, Repatha |
| Glaxosmithkline, LLC. | $29.00 | 2022-2024 | Arexvy, Trelegy Ellipta |
| Dexcom, INC. | $28.74 | 2024 | Dexcom G7 Gss (161) |
| Abbvie INC. | $27.70 | 2022-2023 | |
| Cranial Technologies, INC | $20.61 | 2024 | Doc Band |
| Abbott Laboratories | $17.12 | 2025 | Freestyle Libre 3 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $12.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Pfeifer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.